Geographic atrophy is a subtype of advanced age-related macular degeneration (AMD). It causes blind spots in the center of vision and a permanent loss of visual sharpness. AMD progresses through ...

We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any therapeutics to target the root cause of geographic atrophy, an advanced form of dry AMD ...

Pulsesight Therapeutics SAS has submitted a clinical trial authorization (CTA) to the French authority ANSM seeking to conduct a first-in-human phase I trial of PST-611 for dry age-related macular ...

Brown D. Pegcetacoplan for geographic atrophy in AMD. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago. Jaffe G. Avacincaptad for geographic atrophy in AMD.

Over the past 15 years, I’ve developed wet AMD in my left eye and geographic atrophy (GA) in both eyes. I don’t like to call attention to myself, and people often don’t realize I have vision ...

progressing through successive stages into the late form of dry AMD also called geographic atrophy (GA). Wet AMD is a less common type of late AMD causing faster vision loss. Any stage of dry AMD ...

Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD ...

WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for the every-other-month ...

As a result, GA secondary to AMD has a substantial impact on patients’ daily lives and psychological wellbeing. Marci English, vice president, head of biopharma and ophthalmology development, Astellas ...